[CLINICAL EXPERIMENTATION WITH A NEW SYNTHETIC ANTICOAGULANT, A COUMARIN DERIVATIVE: 1-METHOXY-2, 2-BIS (4-HYDROXY-3-COUMARINYL)-ETHANE].
D000925:Anticoagulants; D001145:Arrhythmias, Cardiac; D035843:Biomedical Research; D003327:Coronary Disease; D003374:Coumarins; D004980:Ethane; D005753:Gastric Mucosa; D005853:Geriatrics; D006333:Heart Failure; D006493:Heparin; D009203:Myocardial Infarction; D013923:Thromboembolism; D014116:Toxicology
D000925:Anticoagulants; D003374:Coumarins; D006493:Heparin; D004980:Ethane
ARRHYTHMIA; CLINICAL RESEARCH; CORONARY DISEASE; COUMARINS; GASTRIC MUCOSA; GERIATRICS; HEART FAILURE, CONGESTIVE; HEPARIN; MYOCARDIAL INFARCT; THROMBOEMBOLISM; TOXICOLOGIC REPORT
EXP'ERIMENTATION CLINIQUE D'UN NOUVEL ANTICOAGULANT DE SYNTH'ESE D'ERIV'E DE LA COUMARINE: LE M'ETHOXY-I-BIS (HYDROXY-4-COUMARINYL-3) 2, 2 'ETHANE.